1
|
Stel VS, Boenink R, Astley ME, Boerstra BA, Radunovic D, Skrunes R, Ruiz San Millán JC, Slon Roblero MF, Bell S, Ucio Mingo P, Ten Dam MAGJ, Ambühl PM, Resic H, Rodríguez Arévalo OL, Aresté-Fosalba N, Tort I Bardolet J, Lassalle M, Trujillo-Alemán S, Indridason OS, Artamendi M, Finne P, Rodríguez Camblor M, Nitsch D, Hommel K, Moustakas G, Kerschbaum J, Lausevic M, Jager KJ, Ortiz A, Kramer A. A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS. Nephrol Dial Transplant 2024:gfae040. [PMID: 38439701 DOI: 10.1093/ndt/gfae040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2024] Open
Abstract
BACKGROUND AND HYPOTHESIS This paper compares the most recent data on the incidence and prevalence of kidney replacement therapy (KRT), kidney transplantation rates, and mortality on KRT from Europe to those from the United States (US), including comparisons of treatment modalities (haemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KTx)). METHODS Data were derived from the annual reports of the European Renal Association (ERA) Registry and the United States Renal Data System (USRDS). The European data include information from national and regional renal registries providing the ERA Registry with individual patient data. Additional analyses were performed to present results for all participating European countries together. RESULTS In 2021, the KRT incidence in the US (409.7 per million population (pmp)) was almost 3-fold higher than in Europe (144.4 pmp). Despite the substantial difference in KRT incidence, approximately the same proportion of patients initiated HD (Europe: 82%, US: 84%), PD (14%; 13% respectively), or underwent pre-emptive KTx (4%; 3% respectively). The KRT prevalence in the US (2436.1 pmp) was 2-fold higher than in Europe (1187.8 pmp). Within Europe, approximately half of all prevalent patients were living with a functioning graft (47%), while in the US, this was one third (32%). The number of kidney transplantations performed was almost twice as high in the US (77.0 pmp) compared to Europe (41.6 pmp). The mortality of patients receiving KRT was 1.6-fold higher in the US (157.3 per 1000 patient years) compared to Europe (98.7 per 1000 patient years). CONCLUSIONS The US had a much higher KRT incidence, prevalence, and mortality compared to Europe, and despite a higher kidney transplantation rate, a lower proportion of prevalent patients with a functioning graft.
Collapse
Affiliation(s)
- Vianda S Stel
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands
| | - Rianne Boenink
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands
| | - Megan E Astley
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands
| | - Brittany A Boerstra
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands
| | - Danilo Radunovic
- Clinical Center of Montenegro, Clinic for Nephrology, Podgorica, Montenegro
| | - Rannveig Skrunes
- Department of Medicine, Haukeland university Hospital, Bergen, Norway
- Department of Clinical Medicine, University of Bergen, Bergen, Norway
| | - Juan C Ruiz San Millán
- Nephrology Department, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Cantabria, Spain
| | | | - Samira Bell
- Scottish Renal Registry, Public Health Scotland, Meridian Court, Glasgow, UK
- Division of Population Health and Genomics, University of Dundee, Dundee, UK
| | - Pablo Ucio Mingo
- Coordinación Autonómica de Trasplantes de Castilla y León, Dirección General de Asistencia Sanitaria y Humanización, Gerencia Regional de Salud de Castilla y León, Valladolid, Castilla y León, Spain
| | | | | | - Halima Resic
- Society for Nephrology, Dialysis and Transplantation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina
| | - Olga Lucia Rodríguez Arévalo
- Registry of Kidney Patients of the Valencian Community, General Directorate of Public Health, Ministry of Health, Valencia, Spain
- Health and Well-being Technologies Program, Polytechnic University of Valencia, Valencia, Spain
| | - Nuria Aresté-Fosalba
- Nephrology Department, Virgen Macarena Hospital, Seville, Andalusia, Spain
- Information System of Andalusian Transplant Coordination (SICATA), Seville, Andalusia, Spain
| | - Jaume Tort I Bardolet
- Catalan Transplant Organization (OCATT), Catalan Health Service, Department of Health Barcelona, Spain
| | - Mathilde Lassalle
- REIN registry (Renal Epidemiology and Information Network), Paris, France
| | - Sara Trujillo-Alemán
- Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Las Palmas de Gran Canaria, Spain
| | - Olafur S Indridason
- Division of Nephrology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland
| | - Marta Artamendi
- Nephrology Department, Hospital San Pedro, Logroño, La Rioja, Spain
| | - Patrik Finne
- Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | | | - Dorothea Nitsch
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine. Renal Unit, Royal Free London NHS Foundation Trust. UK Kidney Association, Bristol, UK
| | | | - George Moustakas
- Nephrology department, General hospital of Athens "G.Gennimatas", Athens, Greece
| | - Julia Kerschbaum
- Austrian Dialysis and Transplant Registry, Department of Internal Medicine IV - Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria
| | - Mirjana Lausevic
- School of Medicine, University of Belgrade, Belgrade, Serbia
- Clinic of Nephrology, University Clinical Centre of Serbia, Belgrade, Serbia
| | - Kitty J Jager
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands
| | - Alberto Ortiz
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
- Department of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
| | - Anneke Kramer
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands
| |
Collapse
|
2
|
Boerstra BA, Boenink R, Astley ME, Bonthuis M, Abd ElHafeez S, Arribas Monzón F, Åsberg A, Beckerman P, Bell S, Cases Amenós A, Castro de la Nuez P, ten Dam MAGJ, Debska-Slizien A, Gjorgjievski N, Giudotti R, Helve J, Hommel K, Idrizi A, Indriðason ÓS, Jarraya F, Kerschbaum J, Komissarov KS, Kozliuk N, Kravljaca M, Lassalle M, De Meester JM, Ots-Rosenberg M, Plummer Z, Radunovic D, Razvazhaieva O, Resic H, Rodríguez Arévalo OL, Santiuste de Pablos C, Seyahi N, Slon-Roblero MF, Stendahl M, Tolaj-Avdiu M, Trujillo-Alemán S, Ziedina I, Ziginskiene E, Ortiz A, Jager KJ, Stel VS, Kramer A. The ERA Registry Annual Report 2021: a summary. Clin Kidney J 2024; 17:sfad281. [PMID: 38638342 PMCID: PMC11024806 DOI: 10.1093/ckj/sfad281] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Indexed: 04/20/2024] Open
Abstract
Background The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper is a summary of the ERA Registry Annual Report 2021, including a comparison across treatment modalities. Methods Data was collected from 54 national and regional registries from 36 countries, of which 35 registries from 18 countries contributed individual patient data and 19 registries from 19 countries contributed aggregated data. Using this data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities and expected remaining lifetimes were calculated. Result In 2021, 533.2 million people in the general population were covered by the ERA Registry. The incidence of KRT was 145 per million population (pmp). In incident patients, 55% were 65 years or older, 64% were male, and the most common primary renal disease (PRD) was diabetes (22%). The prevalence of KRT was 1040 pmp. In prevalent patients, 47% were 65 years or older, 62% were male, and the most common PRDs were diabetes and glomerulonephritis/sclerosis (both 16%). On 31 December 2021, 56% of patients received haemodialysis, 5% received peritoneal dialysis, and 39% were living with a functioning graft. The kidney transplantation rate in 2021 was 37 pmp, a majority coming from deceased donors (66%). For patients initiating KRT between 2012-2016, 5-year survival probability was 52%. Compared to the general population, life expectancy was 65% and 68% shorter for males and females receiving dialysis, and 40% and 43% shorter for males and females living with a functioning graft.
Collapse
Affiliation(s)
- Brittany A Boerstra
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Health Behaviours & Chronic Diseases, Amsterdam, The Netherlands
- Amsterdam Public Health, Ageing & Later Life, Amsterdam, The Netherlands
| | - Rianne Boenink
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Ageing & Later Life, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
| | - Megan E Astley
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Health Behaviours & Chronic Diseases, Amsterdam, The Netherlands
- Amsterdam Public Health, Global Health, Amsterdam, The Netherlands
| | - Marjolein Bonthuis
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
- Amsterdam Public Health, Methodology, Amsterdam, The Netherlands
| | - Samar Abd ElHafeez
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt
| | | | - Anders Åsberg
- The Norwegian Renal Registry, Department of Transplantation Medicine, Oslo University Hospital – Rikshospitalet, Oslo, Norway
| | - Pazit Beckerman
- Institute of Nephrology and Hypertension, Sheba Medical Center, Ramat Gan, Israel
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Samira Bell
- Scottish Renal Registry, Public Health Scotland, Glasgow, UK
- Division of Population Health & Genomics, University of Dundee, Ninewells Hospital, Dundee, UK
| | | | - Pablo Castro de la Nuez
- SICATA: Information System of the Autonomous Coordination of Transplants of Andalusia, Seville, Andalusia, Spain
| | | | - Alicja Debska-Slizien
- Department of Nephrology, Transplantology and Internal Medicine, Gdańsk Medical University, Gdańsk, Poland
| | - Nikola Gjorgjievski
- Clinic of Nephrology, Skopje, North Macedonia
- Faculty of Medicine, University ‘SS Cyril and Methodius’ Skopje, Skopje, North Macedonia
| | | | - Jaakko Helve
- Finnish Registry for Kidney Diseases, Helsinki, Finland
- Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Kristine Hommel
- Department of Nephrology, Holbaek Hospital, Holbaek, Denmark
| | - Alma Idrizi
- Service of Nephrology, UHC ‘Mother Teresa’, Tirana, Albania
| | - Ólafur S Indriðason
- Division of Nephrology, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
| | - Faiçal Jarraya
- Research Lab LR19ES11 and Nephrology, Faculty of Medicine, Sfax University, Sfax, Tunisia
| | - Julia Kerschbaum
- Austrian Dialysis and Transplant Registry, Department of Internal Medicine IV – Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria
| | - Kirill S Komissarov
- Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus
| | | | - Milica Kravljaca
- Clinic of Nephrology, Clinical Center of Serbia, Belgrade, Serbia
| | - Mathilde Lassalle
- REIN registry (Renal Epidemiology and Information Network), Agence de la Biomédecine, Saint-Denis La Plaine, France
| | | | - Mai Ots-Rosenberg
- Tartu University, Faculty of Medicine, Department of Internal Medicine, Tartu, Estonia
- Tartu University Hospital, Department of Internal Medicine, Tartu, Estonia
| | | | - Danilo Radunovic
- Clinic for Nephrology, Clinical Center of Montenegro, Podgorica, Montenegro
| | | | - Halima Resic
- Society for Nephrology, Dialysis, and Transplantation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina
| | - Olga Lucía Rodríguez Arévalo
- Registry of Kidney Patients of the Valencian Community, General Directorate of Public Health, Ministry of Health, Valencia, Spain
- Health and Well-being Technologies Program, Polytechnic University of Valencia, Valencia, Spain
| | - Carmen Santiuste de Pablos
- Murcia Renal Registry, Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Nurhan Seyahi
- Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Nephrology, Istanbul, Turkey
| | | | - Maria Stendahl
- Swedish Renal Registry, Dept of Internal Medicine, Jonkoping Hospital, Jonkoping, Sweden
| | | | - Sara Trujillo-Alemán
- Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Canary Islands, Spain
| | - Ieva Ziedina
- Center of Nephrology, Pauls Stradins Clinical University Hospital, Riga, Latvia
- Department of Internal Medicine, Riga Stradins University, Riga, Latvia
- Latvian Association of Nephrology, Riga, Latvia
| | - Edita Ziginskiene
- Lithuanian Nephrology, Dialysis and Transplantation Association, Kaunas, Lithuania
- Nephrology Department, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Alberto Ortiz
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
- Department of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
| | - Kitty J Jager
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Ageing & Later Life, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
| | - Vianda S Stel
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Ageing & Later Life, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
| | - Anneke Kramer
- Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands
- Amsterdam Public Health, Methodology, Amsterdam, The Netherlands
| |
Collapse
|
3
|
Astley ME, Boenink R, Abd ElHafeez S, Trujillo-Alemán S, Arribas F, Åsberg A, Beckerman P, Bell S, Bouzas-Caamaño ME, Farnés JC, Galvão AA, Gjorgjievski N, Kelmendi VG, Guidotti R, Helve J, Idrizi A, Indriðason ÓS, Ioannou K, Kerschbaum J, Komissarov K, Castro de la Nuez P, Lassalle M, Nordio M, Arévalo OLR, Santiuste C, Seyahi N, Roblero MFS, Steenkamp R, ten Dam MAGJ, Zakharova EV, Ziginskiene E, Bonthuis M, Stel VS, Ortiz A, Jager KJ, Kramer A. The ERA Registry Annual Report 2020: a summary. Clin Kidney J 2023; 16:1330-1354. [PMID: 37529647 PMCID: PMC10387405 DOI: 10.1093/ckj/sfad087] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Indexed: 08/03/2023] Open
Abstract
Background The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with ESKD. This paper is a summary of the ERA Registry Annual Report 2020, also including comparisons among primary renal disease (PRD) groups. Methods Data were collected from 52 national and regional registries from 34 European countries and countries bordering the Mediterranean Sea: 35 registries from 18 countries providing individual level data and 17 registries from 17 countries providing aggregated data. Using this data, KRT incidence and prevalence, kidney transplantation rates, expected remaining lifetimes and survival probabilities were calculated. Results A general population of 654.9 million people was covered by the ERA Registry in 2020. The overall incidence of KRT was 128 per million population (p.m.p.). In incident KRT patients, 54% were older than 65 years, 63% were men and the most common PRD was diabetes mellitus (21%). Regarding initial treatment modality in incident patients, 85% received haemodialysis (HD), 11% received peritoneal dialysis (PD) and 4% received a pre-emptive kidney transplant. On 31 December 2020, the prevalence of KRT was 931 p.m.p. In prevalent patients, 45% were older than 65 years, 60% were men and glomerulonephritis was the most common PRD (18%). Of these patients, 58% were on HD, 5% on PD and 37% were living with a kidney transplant. The overall kidney transplantation rate in 2020 was 28 p.m.p., with a majority of kidney grafts from deceased donors (71%). The unadjusted 5-year survival, based on incident dialysis patient from 2011-15, was 41.8%. For patients having received a deceased donor transplant, the unadjusted 5-year survival probability was 86.2% and for patients having received a living donor transplant it was 94.4%. When comparing data by PRD group, differences were found regarding the distribution of age groups, sex and treatment modality received.
Collapse
Affiliation(s)
| | - Rianne Boenink
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care and Ageing & Later Life, Amsterdam, The Netherlands
| | - Samar Abd ElHafeez
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt
| | - Sara Trujillo-Alemán
- Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Canary Islands, Spain
| | - Federico Arribas
- Department of Aragon Health, General Direction of Health Care, Zaragoza, Spain
| | - Anders Åsberg
- The Norwegian Renal Registry, Department of Transplantation Medicine, Oslo University Hospital – Rikshospitalet, Oslo, Norway
| | - Pazit Beckerman
- Sheba Medical Center, Ramat Gan, and School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Samira Bell
- Scottish Renal Registry, Public Health Scotland, Glasgow, UK
- Division of Population Health & Genomics, University of Dundee, Ninewells Hospital, Dundee, United Kingdom
| | | | - Jordi Comas Farnés
- Catalan Renal Registry, Catalan Transplant Organization, Health Department, Generalitat of Catalonia, Barcelona, Spain
| | | | - Nikola Gjorgjievski
- Hospital of Nephrology, Skopje, N. Macedonia
- Faculty of Medicine, University “SS Cyril and Methodius” Skopje, Skopje, N. Macedonia
| | | | - Rebecca Guidotti
- Institute of Nephrology, City Hospital Zurich, Zurich, Switzerland
| | - Jaakko Helve
- Finnish Registry for Kidney Diseases and Abdominal Center Nephrology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
| | - Alma Idrizi
- Service of Nephrology, UHC Mother Teresa, Tirana, Albania
| | - Ólafur S Indriðason
- Division of Nephrology, Landspitali–The National University Hospital of Iceland, Reykjavik, Iceland
| | | | - Julia Kerschbaum
- Austrian Dialysis and Transplant Registry, Department of Internal Medicine IV–Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria
| | - Kirill Komissarov
- Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology, Minsk, Belarus
| | - Pablo Castro de la Nuez
- SICATA: Information System of the Autonomous Coordination of Transplants of Andalusia, Seville, Andalucia, Spain
| | - Mathilde Lassalle
- REIN Registry, Agence de la Biomédecine, Saint-Denis La Plaine, France
| | - Maurizio Nordio
- Division of Nephrology, AULSS 2, Treviso General Hospital, Treviso, Italy
| | - Olga Lucía Rodríguez Arévalo
- Registry of Renal Patients of the Valencian Community, General Directorate of Public Health and Addictions, Ministry of Universal Health and Public Health, Valencia, Spain
- Health and Well-being Technologies Program, Polytechnic University of Valencia, Valencia, Spain
| | - Carmen Santiuste
- Murcia Renal Registry, Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Nurhan Seyahi
- Department of Nephrology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey
| | | | | | | | - Elena V Zakharova
- Nephrology, Botkin Hospital, Moscow, Russia
- Nephrology and Hemodialysis, Russian Medical Academy of Continuing Professional Education, Moscow, Russia
| | - Edita Ziginskiene
- Lithuanian Nephrology, Dialysis and Transplantation Association, Kaunas, Lithuania
- Nephrology Department, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Marjolein Bonthuis
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
- ESPN/ERA Registry, Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands
| | - Vianda S Stel
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care and Ageing & Later Life, Amsterdam, The Netherlands
| | - Alberto Ortiz
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
- Department of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
| | - Kitty J Jager
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Public Health, Quality of Care and Ageing & Later Life, Amsterdam, The Netherlands
| | - Anneke Kramer
- ERA Registry, Department of Medical Informatics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
4
|
Boenink R, Astley ME, Huijben JA, Stel VS, Kerschbaum J, Rosenberg-Ots M, Åsberg AA, Lopot F, Golan E, Castro de la Nuez P, Rodríguez Camblor M, Trujillo-Alemán S, Ruiz San Millan JC, Ucio Mingo P, Díaz JM, Bouzas-Caamaño ME, Artamendi M, Aparicio Madre MI, Santiuste de Pablos C, Slon Roblero MF, Zurriaga O, Stendahl ME, Bell S, Idrizi A, Ioannou K, Debska-Slizien A, Galvão AA, De Meester JM, Resić H, Hommel K, Radunovic D, Pálsson R, Lassalle M, Finne P, De los Ángeles-Garcia Bazaga M, Gjorgjievski N, Seyahi N, Bonthuis M, Ortiz A, Jager KJ, Kramer A. The ERA Registry Annual Report 2019: summary and age comparisons. Clin Kidney J 2021; 15:452-472. [PMID: 35211303 PMCID: PMC8862051 DOI: 10.1093/ckj/sfab273] [Citation(s) in RCA: 39] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Indexed: 11/24/2022] Open
Abstract
Background Data on renal replacement therapy (RRT) for end-stage renal disease were collected by
the European Renal Association (ERA) Registry via national and regional renal registries
in Europe and countries bordering the Mediterranean Sea. This article provides a summary
of the 2019 ERA Registry Annual Report, including data from 34 countries and additional
age comparisons. Methods Individual patient data for 2019 were provided by 35 registries and aggregated data by
17 registries. Using these data, the incidence and prevalence of RRT, the kidney
transplantation activity and the survival probabilities were calculated. Results In 2019, a general population of 680.8 million people was covered by the ERA Registry.
Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these
patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as
primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis
(PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The
overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on
HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate
was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted
5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for
recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in
the period 2010–14. When comparing age categories, there were substantial differences in
the distribution of PRD, treatment modality and kidney donor type, and in the survival
probabilities.
Collapse
Affiliation(s)
- Rianne Boenink
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Megan E Astley
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Jilske A Huijben
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Vianda S Stel
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Julia Kerschbaum
- Austrian Dialysis and Transplant Registry, Department of Internal Medicine IV - Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria
| | - Mai Rosenberg-Ots
- Department of Internal Medicine of Tartu University and Tartu University Hospital, Tartu, Estonia
| | - Anders A Åsberg
- The Norwegian Renal Registry, Oslo University Hospital - Rikshospitalet, Oslo, Norway
- Department of Transplantation Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway
| | - Frantisek Lopot
- Department of Medicine, General University Hospital, Prague – Strahov, Czech Republic
| | | | - Pablo Castro de la Nuez
- SICATA: Information System of the Autonomous Coordination of Transplants of Andalusia, Seville, Andalucia, Spain
| | | | - Sara Trujillo-Alemán
- Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Canary Islands, Spain
| | | | - Pablo Ucio Mingo
- Coordinación Autonómica de Trasplantes de Castilla y León, Dirección General de Planificación y Asistencia Sanitaria, Valladolid, Castilla y León, Spain
| | - Joan Manuel Díaz
- Servei Nefrologia, Fundació Puigvert, Barcelona, Catalonia, Spain
| | | | - Marta Artamendi
- Nephrology Department, Hospital San Pedro, Logroño, La Rioja, Spain
| | | | - Carmen Santiuste de Pablos
- Murcia Renal Registry, Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain
- CIBERESP (Spanish Consortium for Biomedical Research in Epidemiology and Public Health), Madrid, Spain
| | | | - Oscar Zurriaga
- CIBERESP (Spanish Consortium for Biomedical Research in Epidemiology and Public Health), Madrid, Spain
- Valencian Region Renal Registry, Valencia Regional Health Authority, Generalitat Valenciana, Spain
- Universitat de Valencia, Valencia, Spain
| | - Maria E Stendahl
- Swedish Renal Registry, Department of Internal Medicine, Jonkoping Regional Hospital, Jonkoping, Sweden
| | - Samira Bell
- Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK
- The Scottish Renal Registry, Scottish Health Audits, Public Health Scotland, Meridian Court, Glasgow, UK
| | - Alma Idrizi
- Service of Nephrology, UHC Mother Teresa, Tirana, Albania
| | - Kyriakos Ioannou
- Cyprus Renal Registry, Nicosia, Cyprus
- Nephrology Department, American Medical Center, Nicosia, Cyprus
| | - Alicja Debska-Slizien
- Department of Nephrology, Transplantology and Internal Medicine, Gdansk Medical University, Gdansk, Poland
| | - Ana A Galvão
- Portuguese Society of Nephrology, Coimbra, Portugal
| | - Johan M De Meester
- Department of Nephrology, Dialysis and Hypertension, Dutch-speaking Belgian Renal Registry (NBVN), Sint-Niklaas, Belgium
| | - Halima Resić
- Society of nephrology and dialysis of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina
| | | | - Danilo Radunovic
- Clinical Center of Montenegro, Clinic for Nephrology, Podgorica, Montenegro
| | - Runolfur Pálsson
- Division of Nephrology, Landspitali–The National University Hospital of Iceland, Reykjavik, Iceland
- Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
| | - Mathilde Lassalle
- REIN Registry, Agence de la Biomédecine, Saint-Denis La Plaine, France
| | - Patrik Finne
- Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Finnish Registry for Kidney Diseases, Helsinki, Finland
| | - Maria De los Ángeles-Garcia Bazaga
- Dirección General de Salud Pública, Servicio Extremeño de Salud, Consejería de Sanidad y Políticas Sociales, Junta de Extremadura, Spain
| | - Nikola Gjorgjievski
- University Hospital of Nephrology, Skopje, North Macedonia
- Faculty of Medicine, University SS“ Cyril and Methodius”, Skopje, North Macedonia
| | - Nurhan Seyahi
- Department of nephrology, Cerrahpaşa medical faculty, Istanbul university-Cerrahpaşa, Istanbul, Turkey
| | - Marjolein Bonthuis
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
- ESPN/ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Alberto Ortiz
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
- Department of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
| | - Kitty J Jager
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Anneke Kramer
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| |
Collapse
|
5
|
Kramer A, Boenink R, Stel VS, Santiuste de Pablos C, Tomović F, Golan E, Kerschbaum J, Seyahi N, Ioanou K, Beltrán P, Zurriaga O, Magaz Á, Slon Roblero MF, Gjorgjievski N, Garneata L, Arribas F, Galvão AA, Bell S, Ots-Rosenberg M, Muñoz-Terol JM, Winzeler R, Hommel K, Åsberg A, Spustova V, Palencia García MÁ, Vazelov E, Finne P, Ten Dam MAGJ, Lopot F, Trujillo-Alemán S, Lassalle M, Kolesnyk MO, Santhakumaran S, Idrizi A, Andrusev A, Comas Farnés J, Komissarov K, Resić H, Palsson R, Kuzema V, Garcia Bazaga MA, Ziginskiene E, Stendahl M, Bonthuis M, Massy ZA, Jager KJ. The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J 2020; 14:107-123. [PMID: 33564410 PMCID: PMC7857839 DOI: 10.1093/ckj/sfaa271] [Citation(s) in RCA: 54] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Accepted: 12/18/2020] [Indexed: 11/13/2022] Open
Abstract
Background The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. Methods Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. Results In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.
Collapse
Affiliation(s)
- Anneke Kramer
- Department of Medical Informatics, ERA-EDTA Registry, UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Rianne Boenink
- Department of Medical Informatics, ERA-EDTA Registry, UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Vianda S Stel
- Department of Medical Informatics, ERA-EDTA Registry, UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| | - Carmen Santiuste de Pablos
- Department of Epidemiology, Murcia Renal Registry, Murcia Regional Health Authority, IMIB-Arrixaca, Murcia, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Filip Tomović
- Clinical Center of Montenegro, Clinic for Nephrology, Podgorica, Montenegro
| | - Eliezer Golan
- Israel Renal Registry, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - Julia Kerschbaum
- Department of Internal Medicine IV-Nephrology and Hypertension, Austrian Dialysis and Transplant Registry, Medical University Innsbruck, Innsbruck, Austria
| | - Nurhan Seyahi
- Department of Nephrology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey
| | - Kyriakos Ioanou
- Cyprus Renal Registry, Nicosia, Cyprus.,Department of Nephrology, American Medical Center, Nicosia, Cyprus
| | | | - Oscar Zurriaga
- Valencia Region Renal Registry, Direccio General de Salut Publica i Adiccions, Valencia, Spain.,Department of Preventive Medicine and Public Health, Universitat de Valencia, Valencia, Spain.,Rare Diseases Joint Research Unit Universitat de Valencia-Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, FISABIO, Valencia, Spain.,Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Ángela Magaz
- Unidad de Información de Pacientes Renales-UNIPAR, Basque Country, Spain
| | | | - Nikola Gjorgjievski
- University Hospital of Nephrology, Skopje, N. Macedonia.,Faculty of Medicine, University Ss "Cyril and Methodius" Skopje, Skopje, N. Macedonia
| | - Liliana Garneata
- Department of Internal Medicine and Nephrology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| | - Federico Arribas
- Department of Aragon Health, General Direction of Health Care, Zaragoza, Spain
| | | | - Samira Bell
- Scottish Renal Registry, Meridian Court, Information Services Division Scotland, Glasgow, UK.,Division of Population Health and Genomics, University of Dundee, Dundee, UK
| | - Mai Ots-Rosenberg
- Department of Internal Medicine, University of Tartu, Tartu University Hospital, Tartu, Estonia
| | - José M Muñoz-Terol
- Department of Nephrology, Hospital University Virgen del Rocio, Seville, Spain
| | - Rebecca Winzeler
- Institute of Nephrology, City Hospital Waid and Triemli, Zurich, Switzerland
| | | | - Anders Åsberg
- Department of Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Viera Spustova
- Department of experimental and clinical pharmacotherapy, Slovak Medical University, Bratislava, Slovakia
| | - María Ángeles Palencia García
- Coordinación Autonómica de Trasplantes de Castilla y León, Dirección General de Planificación y Asistencia Sanitaria, Regional de Salud, Valladolid, Spain
| | - Evgueniy Vazelov
- Dialysis clinic, "Alexandrovska" University Hospital, Sofia Medical University, Sofia, Bulgaria
| | - Patrik Finne
- Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,Finnish Registry for Kidney Diseases, Helsinki, Finland
| | | | - František Lopot
- Department of Medicine, General University Hospital Prague, Strahov, Czech Republic
| | - Sara Trujillo-Alemán
- Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Canary Islands, Spain
| | - Mathilde Lassalle
- REIN Registry, Agence de la Biomédecine, Saint-Denis La Plaine, France
| | - Mykola O Kolesnyk
- State Institute of Nephrology, National Academy of Medical Sciences of Ukraine, Kiev, Ukraine
| | | | - Alma Idrizi
- Service of Nephrology, UHC Mother Teresa, Tirana, Albania
| | - Anton Andrusev
- Chronic Dialysis, Russia & CIS Medical Department, Company "Baxter" AO, Moscow, Russia.,Renal Replacement Registry, Russian Dialysis Society, Moscow, Russia
| | - Jordi Comas Farnés
- Health Department, Catalan Renal Registry, Catalan Transplant Organization, Generalitat of Catalonia, Barcelona, Spain
| | - Kirill Komissarov
- Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology, Minsk, Belarus
| | - Halima Resić
- Clinic of Nephrology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia-Herzegovina
| | - Runolfur Palsson
- Division of Nephrology, Landspitali- The National University Hospital of Iceland, Reykjavik, Iceland.,Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
| | - Viktorija Kuzema
- Department of Nephrology, Riga Stradins clinical University Hospital, Riga, Latvia.,Department of Internal Medicine, Riga Stradins University, Riga, Latvia.,Latvian Nephrology Association, Riga, Latvia
| | - Maria Angeles Garcia Bazaga
- Dirección General de Salud Pública, Servicio Extremeño de Salud, Consejería de Sanidad y Políticas Sociales, Junta de Extremadura, Mérida, Spain
| | - Edita Ziginskiene
- Lithuanian Nephrology, Dialysis and Transplantation Association, Kaunas, Lithuania.,Department of Nephrology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Maria Stendahl
- Department of Internal Medicine, Swedish Renal Registry, Jonkoping Regional Hospital, Jonkoping, Sweden
| | - Marjolein Bonthuis
- Department of Medical Informatics, ERA-EDTA Registry, UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands.,Department of Medical Informatics, SPN/ERA-EDTA Registry, UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
| | - Ziad A Massy
- Division of Nephrology, Ambroise Paré University Hospital, Boulogne-Billancourt, France.,Institut National de la Santé et de la Recherche Médicale (INSERM) Unit, 1018 Team 5, Research Centre in Epidemiology and Population Health (CESP), University of Paris Ouest-Versailles-St Quentin-en-Yveline, Villejuif, France
| | - Kitty J Jager
- Department of Medical Informatics, ERA-EDTA Registry, UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands
| |
Collapse
|
6
|
Trujillo-Alemán S, Perez G, Reynolds J, Rueda S, Borrell C. Processes and contexts influencing health inequalities among women who are mothers. J Epidemiol Community Health 2019; 73:897-899. [PMID: 31182438 DOI: 10.1136/jech-2019-212229] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2019] [Revised: 05/17/2019] [Accepted: 05/22/2019] [Indexed: 11/04/2022]
Abstract
This paper presents a conceptual framework that aims to conceptualise the different processes and contexts influencing health inequalities among women who are mothers. On the one hand, four processes are shown: (1) social stratification; (2) route into motherhood; (3) exposure and vulnerability to risk factors; and (4) generation of health inequalities. On the other hand, the role of the socioeconomic and political context, the labour market context, and the social, community and family context, as well as their inter-relationships, are presented. In addition, different family policy models, social values and cultural imperatives are considered.
Collapse
Affiliation(s)
- Sara Trujillo-Alemán
- Health Information System Service, Agència de Salut Pública de Barcelona, Barcelona, Spain.,Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.,Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Las Palmas de Gran Canaria, Spain
| | - Gloria Perez
- Health Information System Service, Agència de Salut Pública de Barcelona, Barcelona, Spain .,Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Jillian Reynolds
- Assessment Area, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain
| | | | - Carme Borrell
- Health Information System Service, Agència de Salut Pública de Barcelona, Barcelona, Spain.,Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| |
Collapse
|
7
|
Trujillo-Alemán S, Pérez G, Puig-Barrachina V, Gotsens M, Reynolds J, Rueda S, Borrell C. Inequalities in health and health behaviours between couple and lone mothers before and during the financial crisis in Spain (2003-2012). SSM Popul Health 2019; 7:100367. [PMID: 30809584 PMCID: PMC6374692 DOI: 10.1016/j.ssmph.2019.100367] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2018] [Revised: 01/23/2019] [Accepted: 01/27/2019] [Indexed: 11/19/2022] Open
Abstract
Lone mothers report worse health and adopt more risky health behaviours than couple mothers, as largely documented in several European countries, but not deeply in Spain. The primary aim of this study was to identify the possible existence of inequalities in health and health behaviours between couple and lone mothers in Spain by occupational social class and employment status. A second aim was to explore whether any inequalities were influenced by the economic crisis beginning in 2008, analysing changes in inequalities between 2003–2004 and 2011–2012. Two waves of the cross-sectional Spanish National Health Survey data were used. Analyses were restricted to mothers aged 16–64 years, with at least one child aged 18 years or younger. The sample consisted of 2982 mothers in 2003–2004 and 3070 in 2011–2012, representing more than 80% of couple mothers. Two health outcomes and two health behaviour measurements were used. Robust Poisson regression was run to estimate inequalities between couple and lone mothers, calculating prevalence ratios adjusted by age and stratified by social class and employment status. We found inequalities in health and health behaviours between couple and lone mothers in Spain amongst the manual social class, with lone mothers reporting a more than 30% higher prevalence of poor self-perceived health and being smoker in both time points of study compared with couple mothers. Furthermore, lone mothers were at 50% higher risk of having at least one selected chronic condition and 86% higher probability of sleeping less than 6 hours/day in 2011–2012 This study could not confirm that inequalities between couple and lone mothers changed in Spain during the study period, although some patterns were noticeable. Inequalities pointed towards an increase amongst mothers in the manual social class with paid employment, while inequalities amongst unemployed mothers (both manual and non-manual social class) pointed towards a decrease. In Spain, there are inequalities in health between couple and lone mothers. These inequalities might be influenced by social class and employment status. Lone mothers in the manual social class showed worse health and health behaviours. Lone mothers in the non-manual social class and employed reported better health. Changes in inequalities were not confirmed (2003–2012), despite the economic crisis.
Collapse
Affiliation(s)
- Sara Trujillo-Alemán
- Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona 08023, Spain.,Universitat Pompeu Fabra, C/ Dr. Aiguader, 88, Barcelona 08003, Spain
| | - Glòria Pérez
- Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona 08023, Spain.,Universitat Pompeu Fabra, C/ Dr. Aiguader, 88, Barcelona 08003, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), C/ Monforte de Lemos, 3-5, Madrid 28029, Spain
| | | | - Mercè Gotsens
- Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona 08023, Spain
| | - Jillian Reynolds
- Agency for Health and Quality Assessment of Catalonia (AQuAS), C/ Roc Boronat, 81-95, Barcelona 08005, Spain
| | - Silvia Rueda
- DEP Institut, C/Aragó, 631-633, Barcelona 08026, Spain
| | - Carme Borrell
- Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona 08023, Spain.,Universitat Pompeu Fabra, C/ Dr. Aiguader, 88, Barcelona 08003, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), C/ Monforte de Lemos, 3-5, Madrid 28029, Spain
| |
Collapse
|
8
|
Palència L, De Moortel D, Artazcoz L, Salvador-Piedrafita M, Puig-Barrachina V, Hagqvist E, Pérez G, Ruiz ME, Trujillo-Alemán S, Vanroelen C, Malmusi D, Borrell C. Gender Policies and Gender Inequalities in Health in Europe: Results of the SOPHIE Project. Int J Health Serv 2016; 47:61-82. [PMID: 27530991 DOI: 10.1177/0020731416662611] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
The aim of this article is to explain the results of the SOPHIE project regarding the effect of gender policies on gender inequalities in health in Europe. We start with the results of a systematic review on how gender regimes and gender equality policies at the country level impact women's health and gender inequalities in health. Then, we report on three empirical analyses on the relationship between different family policy models existing in Europe and gender inequalities in health. Finally we present four case studies on specific examples of gender policies or determinants of gender inequalities in health. The results show that policies that support women's participation in the labor force and decrease their burden of care, such as public services and support for families and entitlements for fathers, are related to lower levels of gender inequality in terms of health. In addition, public services and benefits for disabled and dependent people can reduce the burden placed on family caregivers and hence improve their health. In the context of the current economic crisis, gender equality policies should be maintained or improved.
Collapse
Affiliation(s)
- Laia Palència
- Agència de Salut Pública de Barcelona, Barcelona, Spain .,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain
| | - Deborah De Moortel
- Interface Demography, Department of Sociology, Vrije Universiteit Brussel, Brussels, Belgium
| | - Lucía Artazcoz
- Agència de Salut Pública de Barcelona, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain.,Universitat Pompeu Fabra, Barcelona, Spain
| | - María Salvador-Piedrafita
- Universitat Pompeu Fabra, Barcelona, Spain.,Training Unit in Preventive Medicine and Public Health PSMar-UPF-ASPB, Barcelona, Spain
| | - Vanessa Puig-Barrachina
- Agència de Salut Pública de Barcelona, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain
| | - Emma Hagqvist
- Department of Health Sciences, Mid Sweden University, Östersund, Sweden
| | - Glòria Pérez
- Agència de Salut Pública de Barcelona, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain.,Universitat Pompeu Fabra, Barcelona, Spain
| | - Marisol E Ruiz
- Universitat Pompeu Fabra, Barcelona, Spain.,Grup de Recerca en Desigualtats en Salut - Employment Conditions Network (GREDS-EMCONET), Barcelona, Spain
| | - Sara Trujillo-Alemán
- Agència de Salut Pública de Barcelona, Barcelona, Spain.,Universitat Pompeu Fabra, Barcelona, Spain.,Preventive Medicine Service, Hospital General de Fuerteventura, Puerto del Rosario, Spain
| | - Christophe Vanroelen
- Interface Demography, Department of Sociology, Vrije Universiteit Brussel, Brussels, Belgium.,Grup de Recerca en Desigualtats en Salut - Employment Conditions Network (GREDS-EMCONET), Barcelona, Spain
| | - Davide Malmusi
- Agència de Salut Pública de Barcelona, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain
| | - Carme Borrell
- Agència de Salut Pública de Barcelona, Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain.,Universitat Pompeu Fabra, Barcelona, Spain
| |
Collapse
|
9
|
Quori A, Trujillo-Alemán S, Molina-Cabrillana J, Ojeda-García I, Dorta-Hung E, Ojeda-Vargas MM. [Improvement in urinary tract infections rates in a department of internal medicine]. Rev Calid Asist 2013; 28:36-41. [PMID: 22867949 DOI: 10.1016/j.cali.2012.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2012] [Revised: 06/14/2012] [Accepted: 06/16/2012] [Indexed: 06/01/2023]
Abstract
OBJECTIVE To evaluate the impact on the urinary tract infections (UTI) rates of an intervention implemented in the Department of Internal Medicine of the Hospital Universitario Insular de Gran Canaria. MATERIAL AND METHODS Infection control practitioners implemented a three phase project, each lasting two months, focusing on surveillance and feed-back, between 2009 and 2011. During phases 1 and 2, the 2004 Centers for Disease Control and Prevention (CDC)-diagnostic criteria for nosocomial infections were followed, and only rates of infections were calculated. For phase 3, the criteria published in 2009 were used, and rates of infections plus processes rates were obtained. The cumulative incidence of UTI in the three periods was compared using a chi-square for trends test. RESULTS The total number of catheter days, as well as the cumulative incidence of UTI dropped from phase 1 to 3. Nevertheless, in phase 2 the mean urinary catheter days increased. We detected a decrease in the UTI rates and urinary catheter days mean after introducing an electronic reminder in the patient electronic charts. CONCLUSIONS A multidisciplinary approach, including surveillance, reminders, and feed-back, has proved useful in controlling UTI rates in our hospital.
Collapse
Affiliation(s)
- A Quori
- Servicio de Medicina Preventiva, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain.
| | | | | | | | | | | |
Collapse
|